Process for improving adiponitrile quality

Information

  • Patent Grant
  • 8101790
  • Patent Number
    8,101,790
  • Date Filed
    Thursday, June 12, 2008
    16 years ago
  • Date Issued
    Tuesday, January 24, 2012
    12 years ago
Abstract
A process and apparatus for reacting deleterious impurities contained in adiponitrile (ADN) comprises feeding ADN and an ozone containing gas into a co-current plug flow reactor containing static mixer elements, to oxidize at least a portion of the impurities, thereby producing a reactor discharge, which is processed to produce an ozone-treated ADN product.
Description
FIELD OF THE INVENTION

This invention relates to a process and apparatus for improving the quality of adiponitrile (ADN). The invention particularly relates to the treatment of ADN with ozone to react with deleterious trace impurities present in the ADN (or to remove such impurities from ADN) which have an adverse effect on the hydrogenation of ADN to form 6-aminocapronitrile (ACN) and hexamethylenediamine (HMD), which are subsequently used in the manufacture of nylon polymers.


BACKGROUND

It is known in the art that nylon, such as nylon 66, can be produced in a multi-step process. In the first step, butadiene (BD) is hydrocyanated with hydrogen cyanide (HCN) in the presence of a homogeneous nickel catalyst to produce adiponitrile (ADN). Subsequently, organic impurities are removed from the ADN to make a refined ADN. Suitable methods for removing the organic impurities include extraction and distillation. See Ostermaier, U.S. Pat. No. 6,331,651, incorporated herein by reference. In the next step, the refined ADN is catalytically hydrogenated to produce HMD or mixtures comprising ACN and HMD. Suitable hydrogenation catalysts include iron-based and Raney type heterogeneous catalysts, such as Raney nickel. In subsequent steps, ACN and HMD are used in the manufacture nylon polymers, such as nylon 6 and nylon 66.


The ADN made in this process contains several impurities that may have an adverse effect on the hydrogenation of the ADN to ACN and HMD. The impurities include: phosphorous (III) compounds (the “P(III) compounds”); 2-cyanocyclopentylideneimine (CPI); and tert-butyl catechol (TBC).


The P(III) compounds are adsorbed on the surface of heterogeneous catalysts and cause poisoning and subsequent deactivation of the iron-based catalyst.


The CPI is hydrogenated to aminomethylcyclopentylamine (AMC) during the hydrogenation of the ADN. The AMC is difficult to separate from the HMD and causes degradation of polymer quality when the HMD is converted to nylon 66 polymer.


The removal of some of these impurities has been addressed in the past. For example, U.S. Pat. No. 6,331,651 (“'651 Patent”) describes the ADN which contains P(III) compounds, which is treated with air containing greater than 0.1% wt. ozone in a reactor which provides rapid mass transfer rates, such as an agitated tank fitted with a gas sparger, a pipeline reactor fitted with a static mixer, a tank fitted with a jet mixer or an absorption column. The '651 patent states that it is believed that the P(III) compounds are converted by the ozone treatment to phosphorous compounds in the +5 oxidation state, which are less injurious to the iron-containing hydrogenation catalyst.


Canadian patent 672,712 describes a process for purifying ADN containing impurities, which can be made by several different processes. One of the identified impurities is CPI. The process comprises contacting the ADN with gaseous ozone at a temperature of between 0 and 110° C., preferably 20-50° C.


U.S. Pat. No. 6,359,178 discloses a process for producing hexamethylene diamine (HMD) by hydrogenating adiponitrile, wherein the ADN recycle stream is purified in a conventional manner, such as treatment with an inorganic acid, an organic acid, an acidic ion exchanger or by treatment with an oxidizing agent such as air, ozone or hydrogen peroxide.


USSR Patent Publication 276033 discusses purification of ADN by contacting it in a vessel with an ozonized air, optionally in the presence of an acid, such as phosphoric acid.


Fisher et al., WO 00/03972, disclose the production of HMD, wherein the recycle of ADN is cleaned in a known manner, e.g., by treatment with an inorganic or organic acid, or an oxidizing agent, such as air, ozone, hydrogen peroxide or an inorganic or organic peroxide.


Heckle, U.S. Pat. No. 4,952,541; Yamada et al U.S. Pat. No. 3,725,459; Pounder et al. U.S. Pat. No. 3,758,545; Nishimura et al., U.S. Pat. No. 3,803,206, disclose different processes for purification of adiponitrile and acrylonitrile or reactants used in such processes.


Nonetheless a need still exists for an improved process using ozone to reduce or eliminate problems associated with impurities in ADN.


SUMMARY OF THE INVENTION

The invention is directed to a process and apparatus for reacting undesirable trace impurities present in ADN with ozone, in such a way that ozone is most effectively utilized, using an effective but inexpensive reactor. This is achieved by feeding ADN (which is usually a refined ADN, which is a liquid), which hereafter may be referred to as ADN feed, and an ozone-containing gas continuously to a co-current plug flow static mixer reactor of this invention, which hereafter may be referred to as a PFSMR, which provides extremely rapid and highly selective reaction of the ozone with the P(III), CPI, and TBC present in the ADN. It has been discovered that the TBC is also adsorbed on the surface of heterogeneous catalysts, which causes catalyst deactivation. It has also been discovered that the TBC increases the yield of the ADN hydrogenation reaction to an undesirable co-product, hexamethyleneimine (HMI), when the iron catalyst is employed in that reaction. As a result, the yield of the desired HMD is significantly decreased. In addition to the above mentioned impurities, namely P(III), CPI, and TBC, there is a considerable amount of decenedinitrile isomers (which are C10 dinitriles comprising a carbon-carbon double bond), herein referred to as DDN, present in the refined ADN. DDN hydrogenates to impurities that are readily separable from HMD, and it has no adverse affect on hydrogenation catalyst life.


In particular, in one embodiment, the invention is directed to a process for reacting at least a portion of the impurities present in refined ADN to less deleterious compounds comprising: introducing the refined ADN feed and an ozone-containing gas to a PFSMR and contacting the ADN feed with the ozone-containing gas in the PFSMR to oxidize at least a portion of the impurities to produce a reactor discharge which includes a gas and an ozone-treated ADN liquid, which includes the unreacted impurities and less deleterious impurities. The “less deleterious compounds” may also be referred to herein as “less deleterious impurities”. The reactor discharge is fed to a suitable apparatus, such as a tank to separate the gas from the liquid. The gas, also referred to as off-gas, may be discharged to the atmosphere, or to a catalytic abatement unit to further reduce the ozone content prior to discharge of the exit gas to the atmosphere, if desired. The de-gassed liquid containing ozone-treated ADN, unreacted impurities, and less deleterious impurities is an ozone-treated ADN product, which is then hydrogenated to ACN and HMD. “Less deleterious compounds” are compounds which have a lesser negative effect on yield and catalyst life in the subsequent ADN hydrogenation process step, than the impurities originally present in the ADN feed. An example of such a less deleterious compound is P(V) formed from the P(III) impurity.





BRIEF DESCRIPTION OF THE DRAWINGS

The embodiments of the present invention are illustrated by way of example, and not by way of limitation, in the figures of the accompanying drawings and in which like reference numerals refer to similar elements and in which:



FIG. 1 shows the consumption of ozone for a plug flow reactor (PFR) versus the fractional conversion of TBC (X TBC) based on a computer simulation of a process for reacting impurities in ADN comprising contacting an ADN feed with an ozone-containing gas, based on conventional reactor selectivity models, as described in Example 2;



FIG. 2 shows the consumption of ozone for a back mixed reactor (CSTR) versus the fractional conversion of TBC (X TBC), for the computer-simulated process described in Example 2;



FIG. 3 shows the improved ozone utilization in a PFR versus in a CSTR for the computer-simulated process described in Example 2.





DETAILED DESCRIPTION OF THE INVENTION

The PFSMR includes static mixers. As is known to those skilled in the art static mixers, often referred to as motionless mixers, are in-line mixing devices which consist of mixing elements (also known as “static mixer elements”) inserted in a length of pipe. There are a variety of element designs available from the various manufactures but all are stationary in use. The energy for mixing is derived from the pressure loss incurred as the process fluids flow through the mixing elements and additional pumping energy is necessary over and above that normally needed for pumping requirements. The number of elements required in any application is dependent on several factors, such as the difficulty of the mixing duty. Generally, more elements are necessary for difficult tasks. See, Hamby et al., Mixing in the Process Industries, 2nd edition, Butterworth Heinemann (1992), incorporated herein by reference in its entirety.


The ozone-containing gas comprises ozone and any carrier gas suitable for use in our invention. Suitable carrier gases are any gases that are substantially inert to the refined ADN at the operating temperatures of this invention, such as air, air diluted with nitrogen, oxygen-enriched air, nitrogen, carbon dioxide, helium, argon, or a combination of two or more of such gases. In one embodiment, the carrier gas is air. The ozone-containing gas may include about 0.1 to about 3.0% wt. of ozone, such as about 1.0 to about 3.0% wt., or about 3.0% wt. of ozone.


In an embodiment, the ADN feed may include at least one of the following impurities: 2-cyanocyclopentylideneimine (CPI), phosphorous (III) compounds (P(III)), decenedinitrile (DDN) or tert-butyl catechol (TBC). Amounts of impurities in the ADN feed and in the ozone-treated ADN product may be measured by any suitable method. For example, phosphorous may be determined by inductively coupled plasma mass spectrometry (ICP) and it is believed that all of the phosphorous present is P(III). CPI and TBC may be determined by liquid chromatography. DDN may be determined by gas chromatography.


The ADN feed may comprise at least one of: about 0.5 to about 10, such as about 2 to about 10 parts per million by weight (ppm) P(III), about 10 to about 200, such as about 10 to about 50 ppm CPI, about 5 to about 100, such as about 10 to about 50 ppm TBC, about 100 to about 600 ppm, such as about 200 to about 400 ppm DDN or a combination thereof. In one embodiment the ADN feed comprises less than 0.1% wt. of all such impurities: (i.e., P (III), CPI, TBC and DDN).


In one embodiment, the ozone-treated ADN comprises less than 1 ppm P(III), less than 5 ppm CPI, and less than 5 ppm TBC.


In another embodiment, the amount of ozone supplied to the process is sufficient to react at least about 10 to about 80% of the impurities present in the ADN feed.


In another embodiment, the amount of ozone supplied to the process is sufficient to react at least about 90% of the TBC from the ADN feed. In yet another embodiment about 0.1 to about 4, such as about 0.1 to about 2 mmoles of ozone per liter of ADN feed is supplied to the PFSMR.


The ADN feed can be produced by any suitable method, such as by the hydrocyanation of butadiene in the presence of a homogeneous nickel(0) catalyst with phosphorous containing ligands. The ADN used in the process of this invention is usually ADN refined by distillation, as described above. The ozone used in the process can be produced by any known methods. In one embodiment, the ozone is produced by passing air through an ozone generator that produces a gaseous stream comprising about 3 wt % ozone.


The process conducted in the PFSMR very efficiently utilizes the ozone. For example, the ozone consumption in the reactor is in excess of 99% of the ozone fed to the reactor. Thus, the content of unreacted ozone in the off-gas is very low. This is significant and advantageous for environmental reasons. There are strict environmental limitations on the discharge of ozone to the atmosphere. The lower the content of ozone in the reactor off-gas, the less costly the treatment of the off-gas to destroy ozone before discharge to the environment.


Without being bound by any theory, it is believed that ozone reacts very rapidly with all of the impurities present in ADN that are listed above. The reactions are so fast that, it is believed, they take place substantially completely in the liquid phase at the gas-liquid interface, and can be described as chemically assisted mass transfer controlled reactions. While all of the reactions are fast, some are faster than others. At a given impurity concentration, the rates of reaction of ozone with the above impurities decrease in the following order: P(III) and CPI>TBC>DDN, where the reaction with DDN is the slowest. This means that when all of these components (i.e., impurities) are present simultaneously, the ozone reacts selectively with these impurities, reacting faster with the faster reacting species.


While ozone reacts slowest with the DDN, the concentration of DDN in the feed ADN is usually more than 4 times the concentration of the combined P(III), CPI, and TBC on a molar basis. This means that the amount of ozone reacting with the DDN increases as the other impurities are depleted. If it is desired to react the other impurities completely with ozone, a considerable amount of ozone may react needlessly with the DDN. Any ozone consumed by the DDN is wasteful since the DDN hydrogenates to impurities that are readily separable from HMD, and the DDN has substantially no adverse effect on hydrogenation catalyst life.


When several different reactions take place in parallel with a single reactant, selectivity toward the more reactive species is favored by running the reaction in a plug flow configuration. A back-mixed configuration, as would be achieved in a continuous agitated tank (CSTR), or a countercurrent configuration, as would be achieved in an absorption tower, cause poorer utilization of the ozone reactant, i.e., higher ozone consumption to achieve the same level of conversion of the undesirable impurities. Therefore, a co-current plug flow configuration is favored for this application.


The reactions occurring in the PFSMR are very fast, and, it is believed (without being bound by any operability theory), the reaction rate is controlled by the rate of mass transfer of ozone from the gas phase to the liquid phase. High mass transfer is favored by high levels of turbulence, and large interfacial areas. Thus, a reactor configuration is required that meets these requirements.


A reactor type used in the process of the invention that provides both co-current flow and exceptionally high mass transfer rates is a plug flow reactor containing static mixers (also referred to herein as “mixers”). These mixers are sections of pipe that contain internal static mixer elements that promote high mass transfer rates. Each section of the pipe may include the static mixer elements, or some sections of the pipe may not include such static mixer elements. Furthermore, static mixer elements included in different pipe sections may be the same or different. Other advantages of these static mixer reactors are they are inexpensive, easy to operate, and require little maintenance. By using such a reactor, ozone utilization for the desired reactions is maximized, and reactor cost is low. Example 2 illustrates the lower ozone consumption obtained with a plug flow reactor versus a backmixed tank reactor. For typical impurity levels, ozone consumption is reduced by about 30% compared to a backmixed reactor.


In addition to providing high reaction rates and ozone selectivity, the PFSMR gives very high conversions of ozone compared to backmixed reactors. Ozone conversions in the PFSMR can exceed 99.9% of the ozone in the feed gas. The amount of ozone present in the gas phase exit of the reactor can be reduced to less than 10 ppm using a properly designed PFSMR, which is about 100 times lower than can be achieved using a backmixed reactor. This reduces the size of the environmental abatement equipment needed to destroy the residual ozone in the reactor exit gas.


In one embodiment, the process of this invention comprises feeding liquid ADN and gaseous air containing about 3% by weight ozone continuously to the PFSMR. The reactor is operated at ambient conditions. The amount of ozone is adjusted to react almost completely with the P(III), CPI, and TBC, while minimizing the unavoidable reaction of ozone with the DDN. However, the presence of the DDN has the advantage of providing a buffer to consume any excess ozone fed to the process, and eliminate any residual ozone in the exit gas, which alleviates, or eliminates the problem of ozone discharge to the atmosphere.


The design of a plug flow reactor with static mixer elements, such as the PFSMR of this invention, includes a number of steps. Step one is to determine the amount of ozone required to react with the impurities present; this is determined by the levels of impurities present and the reaction stoichiometry. Step two is to determine the reactor volume required to give the desired concentration of ozone in the exit gas, which is achieved using appropriate reactor design equations and mass transfer correlations. Chapters 23 and 24 of the book “Chemical Reaction Engineering, 3rd Edition” by Octave Levenspiel (incorporated herein by reference) discusses the reactor design equations. The mass transfer parameter, kLa, for static mixers which can be used in this invention may be obtained using proprietary correlations supplied by static mixer vendors, and it typically ranges from 0.1 to 2 seconds−1 (Harnby et al.). In step three, the reactor diameter is chosen to give suitably high mass transfer rates, coupled with acceptable pressure drop across the reactor. Desirable pressure drop across the reactor is at least about 1 atmosphere (101.3 kPa). Suitable mass transfer rates in the reactor are obtained with a mass transfer parameter kLa of about 0.1 seconds−1 or greater, preferably about 0.5 seconds−1 or greater, such as about 0.1 to about 2 seconds−1. This is done using vendor correlations for the equipment chosen. Once the reactor volume and diameter are known, reactor length is determined. Once the reactor length and diameter are determined, the reactor is purchased from a vendor as lengths of pipe containing internal static mixer elements. Another important parameter is residence time (also known as “hold-up” time). Residence time for the PFSMR used in our process is about 2 to about 8 seconds, such as about 2 to about 4 seconds e.g., 2.5 or 3 seconds. A desired ozone dosage can be calculated based on impurity levels in the refined ADN. The feed rate of ozone is adjusted to achieve the desired ozone dosage for a given feed rate of and impurity content in refined ADN liquid. One way to adjust the ozone feed rate is to adjust the concentration of ozone in the ozone-containing gas fed to the PFSMR. The process of this invention is particularly easy to control because increasing liquid feed rate simultaneously causes a reduction in holdup time and an increase in kLa such that the conversion of ozone remains relatively constant. Decreasing the liquid feed rate simultaneously causes an increase in holdup time and a decrease in kLa such that the conversion of ozone remains relatively constant. The refined ADN and ozone-containing gas feeds to the reactor operate at sufficient pressure to overcome the design pressure drop across the reactor, as determined in step three. Typically this reactor operates at a temperature less than 50° C., such as ambient temperature. The ozone containing gas and ADN are fed simultaneously or substantially simultaneously into the reactor inlet, and the reactor discharge is fed to a tank, or any other suitable apparatus, to separate the gas from the liquid. The gas, which includes the carrier gas and unreacted ozone, is discharged to the atmosphere, or to a catalytic abatement unit to further reduce the ozone content prior to discharge of the exit gas to the atmosphere, if desired. The resulting liquid, including ozone-treated ADN, unreacted impurities and the less deleterious impurities, is then reacted with hydrogen to form ACN and HMD.


EXAMPLE 1

Air was passed at a rate of 30 standard cubic meters per hour through a model SMA 500 S Wedeco ozone generator, to produce an ozone concentration of 1.0 wt % in the air. The ozone containing air stream was fed to the PFSMR, together with a refined adiponitrile stream. The adiponitrile feed rate was 13.2 metric tons per hour. The static mixer contained Sulzer SMV elements. There were a total of six mixer sections, and each section was 6 feet (1.8 m) in length, giving a total static mixer length of 36 feet (11 m). Each 6-foot (1.8-m) long section contained six static mixer elements, each of which was 6 inches (15.2 cm) in length, where each of the elements was separated from each other by 6 inches (15.2 cm) of open pipe, i.e., the pipe without static mixer elements. The diameter of the static mixer was 3 inches (7.6 cm). Based on the measured performance the mass transfer parameter kLa was calculated to be about 0.7 seconds−1. The adiponitrile feed contained 5.7 ppm phosphorous as organic phosphorous-containing compounds, 31 ppm CPI, 2 ppm TBC, and 186 ppm DDN, where ppm designates part per million by weight. After the ozone treatment, the ozone-treated adiponitrile contained <1 ppm CPI, 2 ppm TBC, and 130 ppm DDN. The concentration of TBC was not noticeably reduced because the TBC concentration in the feed was very low, and so its reaction rate was low in comparison to the DDN, which was present in the feed at much higher (almost 100×) concentrations in the feed. It is believed that essentially all of the CPI was destroyed by the ozone, then all of the phosphorous was oxidized from the +3 to +5 oxidation state, since laboratory results show that ozone reacts with CPI and phosphorous at about the same rate. The total hold up time of material in the reactor was 3.7 seconds, and the ozone concentration in the gas exiting the reactor, i.e., air, was 2.5 ppm, which corresponds to a 99.98% conversion of the ozone.


The ozone-treated ADN was hydrogenated with an iron oxide based catalyst. Ozone treatment was started when the ADN hydrogenation catalyst was about half deactivated based on extensive previous plant data. After ozone treatment was initiated, the rate of catalyst deactivation declined to less than half the normal rate, which extended the catalyst life more than two-fold.


EXAMPLE 2

This example illustrates the improved ozone utility that is realized by carrying out the reaction in a plug flow reactor (PFR) versus a backmixed reactor (CSTR). This example is a computer simulation of a process based on conventional reactor selectivity models using experimentally determined relative reaction rate data for various impurities with ozone. In this example, the ADN feed, fed to both simulated reactors, contains the following impurities: 10 ppm P(III), 50 ppm CPI, 25 ppm TBC, and 675 ppm DDN.


The reaction stoichiometries for the reaction of ozone with the impurities present are one mole of ozone each per mole for P(III), CPI, and DDN; for TBC the stoichiometry is three moles of ozone per mole of TBC. Experiments were conducted in which refined ADN was reacted with ozone in a CSTR at atmospheric pressure and ambient temperature. The depletion of P(III), CPI, TBC, and DDN in the CSTR was measured. These data were fitted to a CSTR reactor design model, derived according to Levenspiel, to determine relative reaction rate constants for the reactions of ozone with P(III), CPI, TBC, and DDN. The P(III) and CPI react virtually completely before attack of ozone on the TBC and DDN begins. Then the TBC and DDN compete for the available ozone. The reaction rate constant for the reaction of ozone with TBC is about 85 times larger than the reaction rate constant for the reaction of ozone with DDN, however there is considerably more DDN available to compete for the available ozone. Using the above data it is possible to calculate the amount of ozone consumed per liter of ADN feed for the two simulated reactor configurations at various fractional conversions of DDN. FIG. 1 shows the ozone consumption for a plug flow reactor (PFR), and FIG. 2 shows the consumption for a backmixed reactor (CSTR) versus the fractional conversion of TBC (X TBC). These data show that the ozone consumption required for 90% reaction of the TBC is 1.46 mmoles of ozone per liter of ADN for the PFR, versus 2.11 mmoles of ozone per liter of ADN for the CSTR. This corresponds to 0.65 mmole/liter reduction in ozone demand for 90% reaction of TBC. FIG. 3 clearly illustrates the improved ozone utilization in a PFR vs. a CSTR.


EXAMPLE 3

This example shows the beneficial effect of reducing HMI yield during the manufacture of HMD achieved by treating the ADN with ozone to destroy TBC prior to hydrogenation.


One part by weight ADN was continuously mixed with six parts by weight anhydrous ammonia. This mixture was fed to a bed of heterogeneous iron catalyst, together with a stoichiometric excess of hydrogen gas. A stoichiometric amount of hydrogen is four moles of hydrogen per mole of ADN. The reactor operated at a pressure of approximately 5000 psi (34.5 MPa). The reactor feed temperature was approximately 100° C., and the temperature increased along the length of the bed due to the heat of reaction of ADN and hydrogen.


Initially ozone treated ADN was fed to the reactor for a period of 250 hours. During the period when ozone treated ADN was fed to the reactor the yield from ADN to HMI averaged 0.10% (moles HMI formed per mole ADN reacted×100%). The ADN feed was then switched to ADN that was not ozone treated, and run for an additional 150 hours, and over this period of operation the average yield from ADN to HMI increased to 0.5%. The amount of TBC in the ozone treated ADN was less than 1 ppm, and the amount of TBC in the untreated ADN was about 25 ppm.


While the illustrative compositions, processes, reactors, methods and procedures, have been described with particularity, it will be understood that various other modifications will be apparent to and can be readily made by those ordinarily skilled in the art without departing from the spirit and scope of our disclosure. Accordingly, we do not intend for the scope of the claims of this application to be limited to the examples and descriptions set forth in the application, but rather that the claims be construed as encompassing all novel and unobvious features of the embodiments covered by the claims, including equivalents of such embodiments.

Claims
  • 1. A process for reacting impurities present in adiponitrile (ADN) comprising: introducing ADN feed and an ozone-containing gas to a co-current plug flow static mixer reactor (PFSMR) and contacting the ADN feed with said ozone-containing gas in said PFSMR to oxidize at least a portion of said impurities, to produce a reactor discharge, wherein said impurities include 2-cyanocylcopentylideneimine (CPI), phosphorous (III) compounds (P(III)), from about 5 to about 100 ppm of tert-butyl catechol (TBC) and from about 100 to about 600 ppm of decenedinitrile (DDN).
  • 2. A process of claim 1, wherein the reactor discharge includes a gas and an ozone-treated ADN liquid, which includes unreacted impurities and less deleterious impurities.
  • 3. A process of claim 2, wherein the reactor discharge is conducted to an apparatus which separates the gas from the ozone-treated ADN liquid to produce an off-gas and a degassed liquid, which is an ozone-treated ADN product.
  • 4. A process of claim 3, wherein the off-gas contains less than 10 ppm of ozone and is discharged to the atmosphere or to a catalytic abatement unit.
  • 5. A process of claim 1, wherein the ozone-containing gas comprises ozone and a carrier gas, and wherein said carrier gas is any gas that is substantially inert to the ADN feed at operating temperature of the process.
  • 6. A process of claim 5, wherein the carrier gas is air, air diluted with nitrogen, oxygen-enriched air, nitrogen, carbon dioxide, helium, argon, or a mixture thereof.
  • 7. A process of claim 5, wherein the ozone-containing gas comprises about 0.1 to about 3% wt. of ozone.
  • 8. A process of claim 5, wherein the ozone-containing gas comprises about 3.0% wt. of ozone.
  • 9. A process of claim 1, wherein the ADN feed comprises about 0.5 to about 10 ppm P(III) and about 10 to about 200 ppm CPI.
  • 10. A process of claim 1, wherein the ADN feed comprises about 2 to about 10 ppm P(III), about 10 to about 50 ppm CPI, about 10 to about 50 ppm TBC, and about 200 to about 400 ppm of DDN.
  • 11. A process of claim 3, wherein the ozone-treated ADN product comprises less than 1 ppm P(III), less than 5 ppm CPI, and less than 5 ppm TBC.
  • 12. A process of claim 1, wherein the amount of ozone supplied to the process is sufficient to react at least about 90% of the TBC present in the ADN feed.
  • 13. A process of claim 1, wherein about 0.1 to about 4 mmoles of ozone per liter of the ADN feed is supplied to the process.
  • 14. A process of claim 1 wherein the ADN feed is produced by the hydrocyanation of butadiene using a homogeneous nickel(0) catalyst with phosphorous containing ligands.
  • 15. A process of claim 1 where the ozone is produced by passing air through an ozone generator that produces a gaseous stream comprising about 3 wt % ozone.
  • 16. A process of claim 1, wherein the ozone consumption in the PFSMR is in excess of 99% of the ozone fed to the PFSMR.
  • 17. A process of claim 1, wherein the mass transfer parameter (kLa) is about 0.1 second−1 or greater.
  • 18. A process of claim 1, wherein the mass transfer parameter (kLa) is about 0.5 second−1 or greater.
  • 19. A process of claim 1, wherein the residence time of the ADN feed and the ozone-containing gas in the PFSMR is about 2 to about 8 seconds.
  • 20. A process of claim 1, wherein the residence time of the ADN feed and the ozone-containing gas in the PFSMR is about 2 to about 4 seconds.
  • 21. A process of claim 1, wherein the residence time of the ADN feed and the ozone-containing gas in the PFSMR is about 3 seconds.
  • 22. A process of claim 3, wherein the ozone-treated ADN product is hydrogenated to ACN and HMD.
  • 23. A process of claim 1, wherein the pressure drop across the PFSMR is at least about 1 atmosphere (101.3 kPa).
US Referenced Citations (163)
Number Name Date Kind
2768132 Halliwell Oct 1956 A
3370082 Eisfeld et al. Feb 1968 A
3496215 Drinkard et al. Feb 1970 A
3496217 Drinkard, Jr. et al. Feb 1970 A
3496218 Drinkard, Jr. Feb 1970 A
3522288 Drinkard, Jr. et al. Jul 1970 A
3536748 Drinkard, Jr. et al. Oct 1970 A
3551474 Drinkard et al. Dec 1970 A
3564040 Downing et al. Feb 1971 A
3579560 Drinkard et al. May 1971 A
3655723 Drinkard, Jr. et al. Apr 1972 A
3694485 Drinkard, Jr. et al. Sep 1972 A
3725459 Yamada et al. Apr 1973 A
3752839 Drinkard, Jr. et al. Aug 1973 A
3758545 Pounder et al. Sep 1973 A
3766231 Gosser et al. Oct 1973 A
3766237 Chia et al. Oct 1973 A
3766241 Drinkard, Jr. et al. Oct 1973 A
3773809 Walter Nov 1973 A
3775461 Drinkard, Jr. et al. Nov 1973 A
3798256 King et al. Mar 1974 A
3803206 Nishimura et al. Apr 1974 A
3818067 Downing et al. Jun 1974 A
3818068 Wells Jun 1974 A
3846474 Mok Nov 1974 A
3849472 Waddan Nov 1974 A
3850973 Seidel et al. Nov 1974 A
3853754 Gosser Dec 1974 A
3853948 Drinkard, Jr. et al. Dec 1974 A
3864380 King et al. Feb 1975 A
3869501 Waddan Mar 1975 A
3920721 Gosser Nov 1975 A
3927056 Gosser Dec 1975 A
3947487 Crooks Mar 1976 A
4045495 Nazarenko et al. Aug 1977 A
4046815 Nazarenko Sep 1977 A
4076756 Nazarenko et al. Feb 1978 A
4087452 Kuntz May 1978 A
4146555 Kershaw Mar 1979 A
4147717 Kershaw Apr 1979 A
4177215 Seidel Dec 1979 A
4210558 Crooks Jul 1980 A
4230634 Benzie et al. Oct 1980 A
4240976 Benzie et al. Dec 1980 A
4251468 Nazarenko Feb 1981 A
4328172 Rapoport May 1982 A
4330483 Rapoport May 1982 A
4339395 Barnette et al. Jul 1982 A
4371474 Rapoport Feb 1983 A
4382038 McGill May 1983 A
4385007 Shook, Jr. May 1983 A
4416824 Reimer et al. Nov 1983 A
4416825 Ostermaier Nov 1983 A
4434316 Barnette Feb 1984 A
4539302 Leyendecker et al. Sep 1985 A
4705881 Rapoport Nov 1987 A
4749801 Bealty et al. Jun 1988 A
4774353 Hall et al. Sep 1988 A
4874884 McKinney et al. Oct 1989 A
4952541 Heckle et al. Aug 1990 A
4990645 Back et al. Feb 1991 A
5107012 Grunewald Apr 1992 A
5302756 McKinney Apr 1994 A
5312959 Sieja et al. May 1994 A
5449807 Druliner Sep 1995 A
5488129 Huser et al. Jan 1996 A
5512695 Kreutzer et al. Apr 1996 A
5512696 Kreutzer et al. Apr 1996 A
5523453 Breikss Jun 1996 A
5543536 Tam Aug 1996 A
5663369 Kreutzer et al. Sep 1997 A
5688986 Tam et al. Nov 1997 A
5696280 Shapiro Dec 1997 A
5709841 Reimer Jan 1998 A
5723641 Tam et al. Mar 1998 A
5773637 Cicha et al. Jun 1998 A
5821378 Foo et al. Oct 1998 A
5847191 Bunel et al. Dec 1998 A
5856555 Huser et al. Jan 1999 A
5908805 Huser et al. Jun 1999 A
5959135 Garner et al. Sep 1999 A
6090987 Billig et al. Jul 2000 A
6121184 Druliner et al. Sep 2000 A
6147247 Voit et al. Nov 2000 A
6169198 Fischer et al. Jan 2001 B1
6171996 Garner et al. Jan 2001 B1
6197992 Fischer et al. Mar 2001 B1
6242633 Fischer et al. Jun 2001 B1
6284865 Tam et al. Sep 2001 B1
6307109 Kanel et al. Oct 2001 B1
6331651 Ostermaier Dec 2001 B1
6355833 Fischer et al. Mar 2002 B2
6359178 Fischer et al. Mar 2002 B1
6461481 Barnette et al. Oct 2002 B1
6469194 Burattin et al. Oct 2002 B2
6521778 Fischer et al. Feb 2003 B1
6646148 Kreutzer Nov 2003 B1
6660877 Lenges et al. Dec 2003 B2
6737539 Lenges et al. May 2004 B2
6753440 Druliner et al. Jun 2004 B2
6770770 Baumann et al. Aug 2004 B1
6846945 Lenges et al. Jan 2005 B2
6852199 Jungkamp et al. Feb 2005 B2
6855799 Tam et al. Feb 2005 B2
6897329 Jackson et al. May 2005 B2
6984604 Cobb et al. Jan 2006 B2
7022866 Bartsch et al. Apr 2006 B2
7067685 Bartsch et al. Jun 2006 B2
7084293 Rosier et al. Aug 2006 B2
7084294 Jungkamp et al. Aug 2006 B2
7098358 Burattin et al. Aug 2006 B2
7105696 Burattin et al. Sep 2006 B2
7253298 Galland et al. Aug 2007 B2
7345006 Bartsch et al. Mar 2008 B2
7381845 Weiskopf et al. Jun 2008 B2
7439381 Jungkamp et al. Oct 2008 B2
7442825 Galland et al. Oct 2008 B2
7470805 Rosier et al. Dec 2008 B2
7521575 Bartsch et al. Apr 2009 B2
7528275 Bartsch et al. May 2009 B2
7538240 Jungkamp et al. May 2009 B2
7541486 Scheidel et al. Jun 2009 B2
7700795 Haderlein et al. Apr 2010 B2
20030135014 Radu et al. Jul 2003 A1
20030212298 Brasse et al. Nov 2003 A1
20040063991 Burattin et al. Apr 2004 A1
20040176622 Bartsch et al. Sep 2004 A1
20040235648 Bartsch et al. Nov 2004 A1
20040260112 Basset et al. Dec 2004 A1
20050090677 Bartsch et al. Apr 2005 A1
20050090678 Bartsch et al. Apr 2005 A1
20050247624 Jungkamp et al. Nov 2005 A1
20060142609 Bourgeois et al. Jun 2006 A1
20060175189 Gerber et al. Aug 2006 A1
20060252955 Rosier et al. Nov 2006 A1
20060258873 Rosier et al. Nov 2006 A1
20060258874 Bartsch et al. Nov 2006 A1
20060264651 Bartsch et al. Nov 2006 A1
20070060766 Bartsch et al. Mar 2007 A1
20070073071 Haderlein et al. Mar 2007 A1
20070083057 Haderlein et al. Apr 2007 A1
20070088173 Haderlein et al. Apr 2007 A1
20070112215 Jungkamp et al. May 2007 A1
20070155977 Jungkamp et al. Jul 2007 A1
20070155978 Jungkamp et al. Jul 2007 A1
20070155980 Scheidel et al. Jul 2007 A1
20080015378 Foo et al. Jan 2008 A1
20080015380 Foo et al. Jan 2008 A1
20080015381 Foo et al. Jan 2008 A1
20080015382 Foo et al. Jan 2008 A1
20080071105 Bartsch et al. Mar 2008 A1
20080076944 Bartsch et al. Mar 2008 A1
20080083607 Deckert et al. Apr 2008 A1
20080221351 Bartsch et al. Sep 2008 A1
20080227214 Jungkamp et al. Sep 2008 A1
20080227998 Scheidel et al. Sep 2008 A1
20080242883 Jungkamp et al. Oct 2008 A1
20080242885 Jungkamp et al. Oct 2008 A1
20080242886 Bartsch et al. Oct 2008 A1
20080275266 Bartsch et al. Nov 2008 A1
20080281119 Scheidel et al. Nov 2008 A1
20080281120 Jungkamp et al. Nov 2008 A1
20090054671 Haderlein et al. Feb 2009 A1
Foreign Referenced Citations (480)
Number Date Country
6522096 Feb 1997 AU
199665220 Feb 1997 AU
672712 Oct 1963 CA
1324613 Nov 1993 CA
2462720 Apr 2003 CA
2552862 Aug 2005 CA
1113854 Dec 1995 CN
1145531 Mar 1997 CN
1146166 Mar 1997 CN
1146762 Apr 1997 CN
1159106 Sep 1997 CN
1159799 Sep 1997 CN
1163606 Oct 1997 CN
1169143 Dec 1997 CN
1173935 Feb 1998 CN
1179147 Apr 1998 CN
1198151 Nov 1998 CN
1204111 Jan 1999 CN
1206357 Jan 1999 CN
1211931 Mar 1999 CN
1045591 Oct 1999 CN
1236355 Nov 1999 CN
1047163 Dec 1999 CN
1245489 Feb 2000 CN
1247102 Mar 2000 CN
1052718 May 2000 CN
1265094 Aug 2000 CN
1266424 Sep 2000 CN
1270543 Oct 2000 CN
1068307 Jul 2001 CN
1304334 Jul 2001 CN
1069310 Aug 2001 CN
1072980 Oct 2001 CN
1076342 Dec 2001 CN
1327881 Dec 2001 CN
1331843 Jan 2002 CN
1333745 Jan 2002 CN
1082946 Apr 2002 CN
1344180 Apr 2002 CN
1356335 Jul 2002 CN
1387534 Dec 2002 CN
1099912 Jan 2003 CN
1390241 Jan 2003 CN
1103613 Mar 2003 CN
1106218 Apr 2003 CN
1108643 May 2003 CN
1427807 Jul 2003 CN
1449400 Oct 2003 CN
1461295 Dec 2003 CN
1471510 Jan 2004 CN
1141285 Mar 2004 CN
1142224 Mar 2004 CN
1144781 Apr 2004 CN
1487917 Apr 2004 CN
1152855 Jun 2004 CN
1535179 Oct 2004 CN
1564807 Jan 2005 CN
1568225 Jan 2005 CN
1568226 Jan 2005 CN
1617892 May 2005 CN
1617900 May 2005 CN
1212293 Jul 2005 CN
1639176 Jul 2005 CN
1213051 Aug 2005 CN
1665776 Sep 2005 CN
1670139 Sep 2005 CN
1674989 Sep 2005 CN
1675172 Sep 2005 CN
1222358 Oct 2005 CN
1732148 Feb 2006 CN
1735460 Feb 2006 CN
1245489 Mar 2006 CN
1740183 Mar 2006 CN
1745062 Mar 2006 CN
1767895 May 2006 CN
1260009 Jun 2006 CN
1266424 Jul 2006 CN
1270543 Aug 2006 CN
1274671 Sep 2006 CN
1274699 Sep 2006 CN
1835915 Sep 2006 CN
1279088 Oct 2006 CN
1847288 Oct 2006 CN
1283620 Nov 2006 CN
1857775 Nov 2006 CN
1289539 Dec 2006 CN
1293942 Jan 2007 CN
1906150 Jan 2007 CN
1914154 Feb 2007 CN
1914155 Feb 2007 CN
1914156 Feb 2007 CN
1914157 Feb 2007 CN
1914158 Feb 2007 CN
1914159 Feb 2007 CN
1914160 Feb 2007 CN
1914161 Feb 2007 CN
1914162 Feb 2007 CN
1914165 Feb 2007 CN
1914166 Feb 2007 CN
1914167 Feb 2007 CN
1914216 Feb 2007 CN
1307237 Mar 2007 CN
1315790 May 2007 CN
1318432 May 2007 CN
1997624 Jul 2007 CN
1331843 Aug 2007 CN
101020641 Aug 2007 CN
101035799 Sep 2007 CN
101043946 Sep 2007 CN
100348322 Nov 2007 CN
100351227 Nov 2007 CN
100352824 Dec 2007 CN
100361966 Jan 2008 CN
100364666 Jan 2008 CN
1807088 Mar 1960 DE
1807088 Jun 1969 DE
2055747 May 1971 DE
1593277 Aug 1973 DE
1593277 Mar 1974 DE
2700904 Oct 1983 DE
68909466 Mar 1994 DE
10136488 Feb 2003 DE
10150285 Apr 2003 DE
10350999 Jun 2005 DE
102004004696 Aug 2005 DE
0001899 Mar 1982 EP
123438 Jul 1987 EP
160296 Oct 1988 EP
268448 Sep 1991 EP
510689 Oct 1992 EP
248643 Mar 1993 EP
336314 Sep 1993 EP
464691 Dec 1993 EP
675871 Apr 1997 EP
634395 Sep 1997 EP
650959 Sep 1997 EP
784610 Feb 1999 EP
757672 Jun 1999 EP
792259 Aug 1999 EP
804412 Dec 1999 EP
1000019 May 2000 EP
1001928 May 2000 EP
1003716 May 2000 EP
1019190 Jul 2000 EP
755302 Oct 2000 EP
929513 Apr 2001 EP
881924 May 2001 EP
854858 Jun 2001 EP
815073 Jul 2001 EP
1144114 Sep 2001 EP
1091804 Feb 2002 EP
944585 Apr 2002 EP
1000019 Feb 2003 EP
911339 Apr 2003 EP
1216268 Nov 2003 EP
1350788 Nov 2003 EP
1003607 Dec 2003 EP
1003716 Feb 2004 EP
1313743 Mar 2004 EP
1414567 May 2004 EP
1427695 Jun 2004 EP
1438133 Jul 2004 EP
1019190 Dec 2004 EP
1140801 Feb 2005 EP
1395547 Mar 2005 EP
1001928 Apr 2005 EP
1521736 Apr 2005 EP
1521737 Apr 2005 EP
1521738 Apr 2005 EP
1603865 Dec 2005 EP
1324976 Feb 2006 EP
1214975 Mar 2006 EP
1324978 Mar 2006 EP
1648860 Apr 2006 EP
891323 Jun 2006 EP
1226147 Jun 2006 EP
1438317 Jun 2006 EP
1682561 Jul 2006 EP
1448668 Aug 2006 EP
1587621 Aug 2006 EP
1713759 Oct 2006 EP
1713761 Oct 2006 EP
1713762 Oct 2006 EP
1713766 Oct 2006 EP
1716102 Nov 2006 EP
1716103 Nov 2006 EP
1716104 Nov 2006 EP
1716105 Nov 2006 EP
1716106 Nov 2006 EP
1716107 Nov 2006 EP
1716109 Nov 2006 EP
1610893 Mar 2007 EP
1621531 Mar 2007 EP
1438132 Apr 2007 EP
1799697 Jun 2007 EP
1713764 Aug 2007 EP
1713816 Aug 2007 EP
1825914 Aug 2007 EP
1448620 Jun 2008 EP
1817108 Jun 2008 EP
1713760 Jul 2008 EP
1571172 Oct 2008 EP
1988998 Nov 2008 EP
1265832 May 2009 EP
1592659 Jul 2009 EP
1586598 Sep 2009 EP
2098106 Sep 2009 EP
1567478 Oct 2009 EP
1682559 Dec 2009 EP
1630166 Feb 2010 EP
1544656 Nov 1968 FR
2015115 Apr 1970 FR
1603513 May 1971 FR
2069411 Sep 1971 FR
2845379 Dec 2004 FR
2873696 Feb 2006 FR
2873696 Oct 2006 FR
0219474 Jul 1924 GB
1104140 Feb 1968 GB
1203702 Sep 1970 GB
1213175 Nov 1970 GB
1429169 Mar 1976 GB
1429621 Mar 1976 GB
1436932 May 1976 GB
1458322 Dec 1976 GB
1482909 Aug 1977 GB
2007521 May 1979 GB
1565443 Apr 1980 GB
1594694 Aug 1981 GB
2007521 Jun 1982 GB
1025950 Jul 2003 HK
1026383 Jul 2004 HK
1052364 May 2007 HK
48028423 Aug 1973 JP
48028423 Sep 1973 JP
49043924 Dec 1974 JP
50059324 Jun 1975 JP
50059326 Jun 1975 JP
51007649 Mar 1976 JP
52012698 Apr 1977 JP
1013127 Sep 1980 JP
55047031 Nov 1980 JP
57156454 Oct 1982 JP
57156455 Oct 1982 JP
57179144 Nov 1982 JP
1136333 Feb 1983 JP
58067658 May 1983 JP
58126892 Aug 1983 JP
1170710 Oct 1983 JP
58159452 Oct 1983 JP
60044295 Mar 1985 JP
60044295 Oct 1985 JP
62294691 Dec 1987 JP
63135363 Sep 1988 JP
1013127 Apr 1989 JP
1209830 Aug 1989 JP
1136333 Sep 1989 JP
1050220 Oct 1989 JP
1173751 Dec 1989 JP
1565159 Jun 1990 JP
3001298 Jan 1991 JP
1615749 Aug 1991 JP
3205587 Sep 1991 JP
1627124 Nov 1991 JP
1627146 Nov 1991 JP
3069915 Nov 1991 JP
3285878 Dec 1991 JP
1642102 Feb 1992 JP
4012248 Mar 1992 JP
4057050 May 1992 JP
4166155 Jun 1992 JP
4230254 Aug 1992 JP
4057050 Sep 1992 JP
4060532 Sep 1992 JP
4118676 Oct 1992 JP
4128141 Nov 1992 JP
1729140 Jan 1993 JP
1811422 Dec 1993 JP
7025841 Jun 1995 JP
7188144 Jul 1995 JP
2037346 Mar 1996 JP
8504814 May 1996 JP
8157795 Jun 1996 JP
2098106 Oct 1996 JP
2521777 Jan 1997 JP
02623448 Jun 1997 JP
9505586 Jun 1997 JP
9512013 Dec 1997 JP
10505101 May 1998 JP
10506911 Jul 1998 JP
10509954 Sep 1998 JP
02818503 Oct 1998 JP
10512879 Dec 1998 JP
11501660 Feb 1999 JP
11504262 Apr 1999 JP
02911608 Jun 1999 JP
11507297 Jun 1999 JP
03001298 Jan 2000 JP
03069915 Jul 2000 JP
2001500135 Jan 2001 JP
2001506250 May 2001 JP
2001512097 Aug 2001 JP
03205587 Sep 2001 JP
2001516640 Oct 2001 JP
03285878 May 2002 JP
2002517473 Jun 2002 JP
03320424 Sep 2002 JP
2002533321 Oct 2002 JP
03380543 Feb 2003 JP
2003510385 Mar 2003 JP
2003526688 Sep 2003 JP
03478399 Dec 2003 JP
2004501058 Jan 2004 JP
2004507550 Mar 2004 JP
03519410 Apr 2004 JP
03535172 Jun 2004 JP
03553952 Aug 2004 JP
2004534032 Nov 2004 JP
2004535929 Dec 2004 JP
03621133 Feb 2005 JP
2005503410 Feb 2005 JP
2005505610 Feb 2005 JP
2005505611 Feb 2005 JP
2005510588 Apr 2005 JP
2005510605 Apr 2005 JP
2004509942 Oct 2005 JP
2005533095 Nov 2005 JP
2005533096 Nov 2005 JP
2005538075 Dec 2005 JP
03739404 Jan 2006 JP
2004534032 Jan 2006 JP
2004535929 Jan 2006 JP
2006000451 Jan 2006 JP
2006511591 Apr 2006 JP
2006519797 Aug 2006 JP
2006528616 Dec 2006 JP
2007083057 Apr 2007 JP
2007509885 Apr 2007 JP
2007509886 Apr 2007 JP
2007509887 Apr 2007 JP
2007519516 Jul 2007 JP
2007519663 Jul 2007 JP
2007519664 Jul 2007 JP
2007519666 Jul 2007 JP
2007519667 Jul 2007 JP
2007519670 Jul 2007 JP
2007519671 Jul 2007 JP
2007519672 Jul 2007 JP
2007519673 Jul 2007 JP
2007519674 Jul 2007 JP
2007519675 Jul 2007 JP
2007519677 Jul 2007 JP
2007522122 Aug 2007 JP
04012248 Nov 2007 JP
2006515323 Feb 2008 JP
04057050 Mar 2008 JP
04060532 Mar 2008 JP
2006512918 Mar 2008 JP
2008515831 May 2008 JP
2008516907 May 2008 JP
04118676 Jul 2008 JP
04128141 Jul 2008 JP
04166155 Oct 2008 JP
04230254 Feb 2009 JP
198802621 Jul 1988 KR
198802296 Oct 1988 KR
198802296 Oct 1988 KR
199003458 May 1990 KR
199008166 Nov 1990 KR
199104132 Jun 1991 KR
199205087 Jul 1992 KR
2006132885 Dec 2006 KR
2004PA002764 Jun 2004 MX
197700262 Jul 1977 NL
188158 Apr 1992 NL
276033 May 1972 SU
677650 Jul 1979 SU
387874 Apr 2000 TW
400249 Aug 2000 TW
453983 Sep 2001 TW
453985 Sep 2001 TW
455576 Sep 2001 TW
457244 Oct 2001 TW
458959 Oct 2001 TW
519496 Feb 2003 TW
527340 Apr 2003 TW
576837 Feb 2004 TW
580489 Mar 2004 TW
580490 Mar 2004 TW
584623 Apr 2004 TW
592821 Jun 2004 TW
226345 Jan 2005 TW
233438 Jun 2005 TW
245780 Dec 2005 TW
266650 Nov 2006 TW
WO7900193 Apr 1979 WO
WO9414752 Jul 1994 WO
WO9514659 Jun 1995 WO
WO9528228 Oct 1995 WO
WO9529153 Nov 1995 WO
WO9611182 Apr 1996 WO
WO9616022 May 1996 WO
WO9622968 Aug 1996 WO
WO9629303 Sep 1996 WO
WO9703040 Jan 1997 WO
WO9712857 Apr 1997 WO
WO9724183 Jul 1997 WO
WO9736855 Oct 1997 WO
WO9811051 Mar 1998 WO
WO9827054 Jun 1998 WO
WO9906146 Feb 1999 WO
WO9906356 Feb 1999 WO
WO9906359 Feb 1999 WO
WO9913983 Mar 1999 WO
WO9964155 Dec 1999 WO
WO0003972 Jan 2000 WO
WO0001485 Jan 2000 WO
WO0037431 Jun 2000 WO
WO0121684 Mar 2001 WO
WO0136429 May 2001 WO
WO0168247 Sep 2001 WO
WO0168247 Sep 2001 WO
WO0211108 Feb 2002 WO
WO0213964 Feb 2002 WO
WO0218392 Mar 2002 WO
WO0226698 Apr 2002 WO
WO0230854 Apr 2002 WO
WO02053527 Jul 2002 WO
WO02092551 Nov 2002 WO
WO03011457 Feb 2003 WO
WO03018540 Mar 2003 WO
WO03024919 Mar 2003 WO
WO03031392 Apr 2003 WO
WO03033141 Apr 2003 WO
WO03033509 Apr 2003 WO
WO03046019 Jun 2003 WO
WO03046049 Jun 2003 WO
WO03068729 Aug 2003 WO
WO03076394 Sep 2003 WO
WO2004007431 Jan 2004 WO
WO2004007432 Jan 2004 WO
WO2004007435 Jan 2004 WO
WO2004007508 Jan 2004 WO
WO2004060855 Jul 2004 WO
WO2004064994 Aug 2004 WO
WO2004065352 Aug 2004 WO
WO2004080924 Sep 2004 WO
WO2004080948 Sep 2004 WO
WO2004087314 Oct 2004 WO
WO2005019160 Mar 2005 WO
WO2005042156 May 2005 WO
WO2005042157 May 2005 WO
WO2005042547 May 2005 WO
WO2005042549 May 2005 WO
WO2005073167 Aug 2005 WO
WO2005073168 Aug 2005 WO
WO2005073169 Aug 2005 WO
WO2005073170 Aug 2005 WO
WO2005073171 Aug 2005 WO
WO2005073172 Aug 2005 WO
WO2005073173 Aug 2005 WO
WO2005073174 Aug 2005 WO
WO2005073175 Aug 2005 WO
WO2005073176 Aug 2005 WO
WO2005073178 Aug 2005 WO
WO2005073179 Aug 2005 WO
WO2005073241 Aug 2005 WO
WO2006040023 Apr 2006 WO
WO2006042675 Apr 2006 WO
WO2005073166 Mar 2007 WO
WO2007051374 May 2007 WO
WO2007096274 Aug 2007 WO
2007115936 Oct 2007 WO
WO2007115936 Oct 2007 WO
WO2008008926 Jan 2008 WO
WO2008008928 Jan 2008 WO
WO2008008929 Jan 2008 WO
WO2008008930 Jan 2008 WO
WO2008028843 Mar 2008 WO
WO2008062058 May 2008 WO
Related Publications (1)
Number Date Country
20080319219 A1 Dec 2008 US
Provisional Applications (1)
Number Date Country
60943689 Jun 2007 US